AMPEL BioSolutions

Precision med company bringing decision support blood and skin biopsy tests to doctors/patients to determine disease status, molecular pathway & drug options.

[AMPEL BioSolutions @AMPELBio]

Press Release on breakthrough study with @wakeforestmed https://t.co/o50QPIaNzX

[AMPEL BioSolutions @AMPELBio]

@AMPELBio collaborating w/ @wakeforestmed published breakthrough study in @CellRepMed fueling a #precisionmedicine #CardioGENE blood test to predict #genetic susceptibility to #cardiovascular events even w/o traditional risk factors of smoking, high fat diet & sedentary lifestyle

[AMPEL BioSolutions @AMPELBio]

Link to breakthrough study demonstrating blood test to predict susceptibility to cardiovascular events published today in @CellRepMed https://t.co/HEuGNh1Rl6

[AMPEL BioSolutions @AMPELBio]

AMPEL BioSolutions’ new genomics CovGENE product proves to have 90%+ accuracy in predicting severity of COVID-19 in positive patients. https://t.co/q4pSt12qUv
@AmrieAMPEL
#COVID19 #SARS-Cov2 #personalizedmedicine #GeneExpression

[AMPEL BioSolutions @AMPELBio]

We're excited to announce a breakthrough in precision and personalized medicine that could modernize the way doctors treat patients across a wide variety of diseases including autoimmunity, infectious disease and cancer https://t.co/y3a67IJ16R

[NatRevRheumatol @NatRevRheumatol]

Online now! An introduction to machine learning and analysis of its use in rheumatic diseases

#RheumTwitter #rheumatology #MachineLearning #MedEd

https://t.co/aETa7XPCEe

[AMPEL BioSolutions @AMPELBio]

Dr. Grammer to introduce one of AMPEL’s products expected to commercialize in 2022. LuGENE®, a CLIA-certified blood test for patients/physicians, assesses disease state/flares and best drug options for lupus patients. https://t.co/a309PPwR0e

[AMPEL BioSolutions @AMPELBio]

Thank you @vabio @Va_DrugDisc for the opportunity to speak today on the prediction of COVID 19 disease severity and best drug options for patients at the symposium on "Coronavirus: Present and Future

[AMPEL BioSolutions @AMPELBio]

@AmrieAMPEL will be giving a flash talk today at 2:45PM EDT at the Tom Tom Festival. The talk will be on Machine Learning Approaches to Predict Lupus Disease Activity from Gene Expression Data. https://t.co/rqsRk26yaC

[AMPEL BioSolutions @AMPELBio]

Informative webinar on June 23 featuring AMPEL's own @AmrieAMPEL! Click here to register: https://t.co/IMt4Hm338W

[AMPEL BioSolutions @AMPELBio]

Tonight @NBC29 at 5 & 6 will air a discussion on @AMPELBio technology that identifies medicines to blunt lung damage experienced by severe #Covid_19 patients with AMPEL CSO @AmrieAMPEL Tune in Tonight! @BioHealthCR @VanHipp @katevega20

[AMPEL BioSolutions @AMPELBio]

AMPEL is looking for licensing partners to bring it's Covid19 prognostic to market and for scientists with validation datasets to collaborate! #Covid19 @AmrieAMPEL
@VanHipp
@katevega20

https://t.co/dp7zYByzGK

[Van Hipp @VanHipp]

Gene-based test predicts severity of illness in #COVID19 patients & identifies best FDA approved treatments!

@AMPELBio shows what American Small Biz can do! https://t.co/ybhPBfyKgG

[AMPEL BioSolutions @AMPELBio]

CovGENE: AMPEL’s Novel Prognostic Technology Predicts Severity of Illness in COVID19 Patients and Identifies Treatments. learn more https://t.co/6ZOM1viayH #COVIDResearch #covgene https://t.co/jzieQ9frD8

[AMPEL BioSolutions @AMPELBio]

@AMPELBio announces the kickoff of a Series A $12.5M raise to commercialize LuGENETM, a gene-based diagnostic at the Biotech Showcase at JP Morgan Healthcare #personalizedmedicine #precisionmedicine #permedcoalition #lupus #SLE https://t.co/YlQlQRL3B0

[AMPEL BioSolutions @AMPELBio]

AMPEL BioSolutions is at the VCU career fair today, booth 50. Stop by and learn more about our opportunities. @VCU @VCAENGR @VCU_CCTR #MachineLearning #BioInformatics #internships #AI #researcher #immunology #lupus #autoimmunedisease

[AMPEL BioSolutions @AMPELBio]

Nice write up on AMPEL's work on interferons in Lupus, led by Senior Scientist Michelle Catalina. #ai #lupus #machinelearning https://t.co/SL87KumnFk

[AMPEL BioSolutions @AMPELBio]

@AmrieAMPEL will be on NBC29 tonight at 5 & 6:00PM News sharing more about AMPEL's breakthrough news https://t.co/cFdSaCAreS
#lupus #BigData #BigDataAnalytics #MachineLearning #AI #GENE #innovation #personalizedmedicine

[AMPEL BioSolutions @AMPELBio]

@kgmaeda_g Ampel’s promising breakthrough is the news patients have desperately been waiting to hear. We applaud Ampel BioSolutions’s goal to help identify patients’ disease activity in real time. https://t.co/b8l0NtNnFQ

[BioHealth Innovation @BioHealthInnov]

Dr. Amrie Grammer of AMPEL BioSolutions joins host Rich Bendis on BioTalk https://t.co/BhOAGYvtTs

[BioHealth Innovation @BioHealthInnov]

Dr. @AmrieGrammer of AMPEL BioSolutions joins Rich on a new episode of BioTalk. Listen now on iTunes (https://t.co/QuuEM9twSQ), Google Play (https://t.co/gxqkpgamKF), and TuneIn (https://t.co/gxqkpgamKF).